tiprankstipranks
Cormedix Inc. (CRMD)
NASDAQ:CRMD
US Market
CRMD
Cormedix
RESEARCH TOOLSreports
Want to see CRMD full AI Analyst Report?

Cormedix (CRMD) Stock News & Sentiment

1,689 Followers
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on REZZAYO Trial Strength and Safety Profile; $13 Price Target Maintained
3d ago
CRMD
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
Premium
Company Announcements
CorMedix Reports Positive Phase III REZZAYO Prophylaxis Results
4d ago
8K
CRMD
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
Premium
Market News
3 ‘Strong Buy’ Low P/E Stocks with Over 40% Upside
11d ago
GEO
CRMD
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
Premium
Ratings
Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
16d ago
CRMD
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
Premium
Company Announcements
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
2M ago
CRMD
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
Premium
Company Announcements
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
2M ago
8K
CRMD
Buy Rating Maintained as Long-Term Rezzayo Upside Remains Underappreciated Despite Near-Term Weakness
Premium
Ratings
Buy Rating Maintained as Long-Term Rezzayo Upside Remains Underappreciated Despite Near-Term Weakness
2M ago
CRMD
More CRMD News >

CRMD News on the Web

Cormedix: Undervalued Biotech with Differentiated Lead Asset and Attractive Risk‑Reward Justifying a Buy Rating
TipRanks News
Bullish
RBC Capital Sticks to Its Buy Rating for Cormedix (CRMD)
TipRanks News
Bearish
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
Zacks
Bearish
Do Options Traders Know Something About CorMedix Stock We Don't?
Zacks
Bearish
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
TipRanks News
Neutral
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
TipRanks News
Neutral
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
TipRanks News
Bullish
CorMedix price target lowered to $13 from $15 at Leerink
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CRMD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRMD’s Media Buzz Sentiment?
1 articles about CRMD were published this week. In an average week, 1 articles are published.
    What is CRMD’s weekly average amount of articles?
    In an average week, 1 articles about CRMD are published.
      What is CRMD’s News Sentiment?
      100% of articles about CRMD were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week